Trade XBI with: Price/Earnings ttm 17. Top Ten Holdings as of 10/31/2023 Top 10 Holdings in XBI 16. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI has a higher expense ratio than XLV (0. February 15, 2023 — 10:47 am EST. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Diversification. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. 01M), Whalerock Point Partners LLC ($343. The firm has a market cap of $5. 1. XBI has lost 27. 56% vs 0. Learn everything about SPDR S&P Biotech ETF (XBI). SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. VHT has a higher 5-year return than XBI (7. 2% weight, and there are 133 holdings in total in the fund (Figure 1). In XBI, the top five holdings together represent only 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 81% of the total fund's. 84. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. Top 10 Holdings. 33% from the latest price. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 54%. Written by BNK Invest for BNK Invest ->. 1% over the past year to close the last trading session at $81. The weighted harmonic average of closing market price divided by. XBI has an overall POWR Rating of D, equating to a Sell. 88%. Warren Buffett is known for holding onto his S&P 500 stocks forever. Share class size. There is no guarantee the fund will achieve its stated investment objective. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. 46% YTD Daily Total Return ETF Summary. There are 10 biotech ETFs that trade in the United States,. Stock Analysis Chart Headlines Holdings Ownership Ratings. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Please call us for more information - (250). XBI has traded between $64. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. Performance and Risk. Top 10 Holdings. Holdings; Performance; Risk; Advertisement. XBI is suitable for investors seeking to. FBT has a higher 5-year return than XBI (-0. XBI's top 10 holdings account for about 11. Top 10 Holdings (14. As a result, the ETF reached a new 8-month low. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 94 per share, with $121. ETF. XLY News. 47 and a beta of 0. 9%: Israel: 3. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. XBI has lost 27. S. 40 for Nov. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. The XBI has been a leader beating other ETFs YTD, up about 35% until today. XBI: Head-To-Head ETF Comparison. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Total net assets. Advertisement. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. The famed investor's Berkshire Hathaway (. Holdings. 50. Below is the comparison between XBI and XLV. 01%). 75. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. N/A. Holdings AS OF 04/30/2023. Mon, Oct 30, 12:50 PM ET, Market News Video. View complete XBI exchange traded fund holdings for better informed ETF trading. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. In XBI, the top five holdings together represent only 9. In addition to holding 155 positions, its top 10. XBI Holdings5 Beaten-Down ETFs to Buy Now. XBI has a beta of 0. XBI holdings. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. As I understand it, this attribute was added to the methodology to protect against having too. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 93% of its total assets under management. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. Sector Exposure and Top Holdings. This fee is shown as an annual percentage rate (APR). The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. Performance and Risk. Stock Analysis Chart Headlines Holdings Ownership Ratings. Its top 10 holdings account for approximately 16. 60 as the 52 week high point — that compares with a last trade of $77. 7,569,600. According to data from U. 28% IONS Ionis Pharmaceuticals Inc Biotechnology. 53 (+3. It has a total of 153 holdings. View Holdings As of 09/30/2023. XBI has traded between. 12 and $91. Performance and Risk The ETF has lost about -29. $36. 1. 1. Again, top 10 holdings. Free ratings, analyses, holdings, benchmarks, quotes, and news. Please contact [email protected] XBI trading at a recent price near $81. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Implied XBI Analyst Target Price: $135. Both BBH and XBI are ETFs. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. In addition to holding 155 positions, its top 10 holdings make up just 14. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. ETFs are subject to market fluctuation and the risks of their underlying investments. 81 and $97. Here, we set out to define in detail the pharmacokinetics of a well-characterized IDR molecule, IDR-1018. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. Overview. Rated on Jun 30, 2023 Published on Jun 30. US. Fund Analysis. " The 12-month stock price forecast is $22. XBI, whose index recently expanded, also owns only a handful of established biotech companies. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. 66%. Chart. •. Staples:. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 64 per share, with $174. IBB outperformed the S&P 500 last year and did much better than XBI. Year-to-date, the SPDR S&P Biotech ETF has gained about 3. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. $5. Below is the comparison between VHT and XBI. View complete IBB exchange traded fund holdings for. The ETF has lost about -12. XBI holdings. Free ratings, analyses, holdings, benchmarks, quotes, and news. 78% of XBI's total assets under management. XBI has traded between $73. 86% so far this year and is down about -32. Looking at the chart above, XBI's low point in its 52 week range is $100. 11. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. XBI - SPDR® S&P Biotech ETF - Review the XBI stock price, growth, performance,. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Looking at the chart above, XBI's low point in its 52 week range is $61. 0. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 00%) Most Recent Dividend 0. It's trading down (17%) versus LABU, down (68%) in one-year performance. Growth of Hypothetical $10,000. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 0. It can be found in the fund’s most recent prospectus. 60 as the 52 week high point — that compares with a last trade of $77. Looking at the chart above, XBI's low point in its 52 week range is $72. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Last Price Today's Change Today's Volume : Prospectus. The ETF has a beta of 1. So far this year, XBI has lost about -5. 47% vs -5. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). The weighted harmonic average of closing market price divided by. 64 billion, a PE ratio of 11. Below is the comparison between FBT and XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. S. Its top 10 holdings account for approximately 16. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 9. ETFs are subject to market fluctuation and the risks of their underlying investments. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. -listed equities in the biotechnology sector. The vast majority of XBI holdings have less. With XBI trading at a recent price near $131. During this past 52-week period, the fund has traded between. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. 17% for the trailing three-year period, which makes XBI a high. Further, the fund owns $6. Cryptocurrency. Mirati Therapeutics. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. 97. 88%. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. underlying holdings of the fund. VHT has a lower expense ratio than XBI (0. Looking at the chart above, XBI's low point in its 52 week range is $97. London. As of Oct 31 2023. Free ratings, analyses, holdings, benchmarks, quotes, and news. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. 77. The ETF has lost about -12. There is no guarantee the funds will achieve their stated investment objectives. 10(-0. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. It has a total of 153 holdings. 2015. Discover historical prices for XBI stock on Yahoo Finance. As of Oct 31 2023. Figure 1 - XBI ETF top 10 holdings (ssga. Trader's Guide 2024 Ships December 21st. ($423. The. 94 per share, with $107. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. All 142 XBI Holdings. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Seeks to track a modified. LABD. 43. In addition to holding 155 positions, its top 10 holdings make up just 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. S. Across the 192 current stocks in the fund, all holdings have a weighting between 0. In contrast, most. View complete XBI exchange traded fund holdings for better informed ETF trading. 35% vs 0. Performance and Risk The ETF has lost about -3. Looking at the chart above, XBI's low point in its 52 week range is $62. The top ten holdings have a 48. Neena Mishra May 10, 2023. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. S. argenx SE ADR. total market composite index. Meanwhile, XBI equal weights its holdings. Snapshot: XBI. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Summary. Currency in USD. November 03, 2023 — 10:50 am EDT. 81% and is down about -5. Minafi categorizes both of these funds as large funds. 44 per share, with $92. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. 33% so far, and is up roughly 4. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. Currency in USD Follow 2W 10W 9M 72. These are the positions, trades, and weight of all companies in her ARKK Innovation ETF. 18% and is down about -39. 26 during this last 52-week period. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 19%. Below is the comparison between LABU and XBI. 35%). 53 (3. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Below is the comparison between VHT and XBI. In depth view into XBI Price including historical data from 2006, charts and stats. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. Cash and Equivalents. S. N/A. The gross expense ratio is the fund’s total annual operating expenses ratio. Front end load. Visitors trend 2W 10W 9M. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI - SPDR (R) S&P (R) Biotech ETFs top. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 06 as the 52 week high point — that compares with a last trade of $112. 7% vs -5. The firm has a market cap of $5. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). ("Boron One" or the. SPDR S&P Biotech ETF. IMVT. 26% rating in the component of Value. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. VHT vs XBI. Only one of these, AbbVie, is a. 49. $7. 79 in February 2021 and has fallen over (50%) to $76. 78 per share, with $134. The equal weight fund, designed to deliver. Better trading starts here. AMGN. 2. Comparing the most. 5. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. Holding Companies. Mirati. 60 as the 52 week high point — that compares with a last trade of $70. Meanwhile, XBI equal weights its holdings. Market On Millstream The. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. N/A. 11. 12 and $91. 5. Holdings; Performance; Risk; Performance Overview-12. BlackRock Files for Spot Ethereum ETF. Performance and Risk So far this year, XBI has added roughly 1. Company Change % Net. Reply Like (7) q. com. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). 3. SPDR® S&P Biotech ETF XBI: NYSE Arca . ETFs - IBB, PBE, XBI. View complete WCLD exchange traded fund holdings for better informed ETF trading. by Sweta Killa Published on September 18,2023. , and Amgen Inc. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. Sector ETFs. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. Wix. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Both LABU and XBI are ETFs. Carnage in small and micro-cap biotech stocks took XBI from $111. Looking at the chart above, XBI's low point in its 52 week range is $62. Taking a look at the XBI, it peaked at $174. 79 as the 52 week high point — that compares with a last trade of $116. 0. The sale of ETFs is subject to an activity assessment fee (from $0. Top 10 Holdings XBI. 8% of its total assets under management. According to data from U. Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). 66738-1. 96%, and is down about -5. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. 68%. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. News & World Report, XBI. 50(-0. 58%). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 98 and standard deviation of 40. 97. Top 10 Holdings (14. Holdings.